Biotech · Private company
Regimmune Corporation
Track this companyFree. Adds Regimmune Corporation to your Dealase workspace and tells you when its record changes.
Clinical trials30 recruiting or active
Pipeline programs7From trials and the company's site
Disclosed deals0None found yet
Cash runwayNot availablePrivate: no SEC financials
Pipeline7
- Allogeneic Bone Marrow TransplantationPhase 2 · Graft Versus Host DiseaseClinicalTrials.gov · fetched Nov 12, 2026
- Allogeneic Hematopoietic Stem Cell TransplantationPhase 2 · Graft Versus Host DiseaseClinicalTrials.gov · fetched Nov 12, 2026
- Calcineurin InhibitorsPhase 2 · Graft Versus Host DiseaseClinicalTrials.gov · fetched Nov 12, 2026
- Conditioning RegimenPhase 2 · Graft Versus Host DiseaseClinicalTrials.gov · fetched Nov 12, 2026
- MethotrexatePhase 2 · Graft Versus Host DiseaseClinicalTrials.gov · fetched Nov 12, 2026
- RGI-2001Phase 2 · Graft Versus Host DiseaseClinicalTrials.gov · fetched Nov 12, 2026
- RGI-2001Phase 2 · Graft Vs Host DiseaseClinicalTrials.gov · fetched Nov 12, 2026
Clinical trials3
- Haplo Peripheral Blood Sct In GVHD PreventionPHASE1 · COMPLETED · started Aug 14, 2020ClinicalTrials.gov NCT04473911 · fetched Nov 12, 2026
- RGI-2001 for the Prevention of Acute Graft-vs-Host Disease in Subjects Following Allogeneic Hematopoietic Stem Cell TransplantationPHASE2 · COMPLETED · started Nov 25, 2019ClinicalTrials.gov NCT04014790 · fetched Nov 12, 2026
- Intravenous Administration of RGI-2001 in Patient Undergoing Allogenic Hematopoietic Stem Cell Transplantation (AHSCT)PHASE1_PHASE2 · COMPLETED · started Sep 1, 2011ClinicalTrials.gov NCT01379209 · fetched Nov 12, 2026